Health and medical groups criticise a decision by Australia’s chemical regulator to allow the ongoing use of a herbicide they say is linked to Parkinson’s disease. Both reports say the decision has drawn strong backlash from health bodies, which question whether the regulator’s approval takes sufficient account of potential health risks. The reports describe the reaction as condemnatory, using similar language to characterise the approval as “shocking.”
While both sources focus on the criticism of the approval, they present the core point consistently: the herbicide is described as toxic and associated with Parkinson’s disease, and the regulator is permitting its continued use. The coverage does not detail alternative assessments or the regulator’s reasoning in the supplied text. It also does not specify timelines, the specific regulatory body’s internal findings, or whether any mitigation measures accompany approval.
Overall, the articles align on the controversy: health groups challenge the regulatory decision that maintains access to an herbicide they believe poses risks to public health, particularly regarding Parkinson’s disease.
